Please provide your email address to receive an email when new articles are posted on . Risks for rebleeding and mortality were similar regardless of vasoconstrictor therapy duration. Data support ...

Drugs currently marketed for pulmonary arterial hypertension have been able to extend the lives of patients but have shown limitations in their ability to prevent or reverse the disease. A novel ...

Efforts thus far to interrupt the neurological dysfunction underlying Raynaud's have come up short and there aren't many others in the offing, said Frederick M. Wigley, MD, of Johns Hopkins University ...

Impaired vascular function leads to cardiovascular disease. Researchers have found that prolonged sitting impairs forearm cutaneous vasodilation function. They also showed that alternating local skin ...

Inhaled nitric oxide (NO) is a selective pulmonary vasodilator that significantly reduces the neonatal morbidity and mortality associated with pulmonary hypertension (1,2). Given the cost and need for ...